In vitro and in silico study of Aloe vera leaf extract against human breast cancer |
| |
Authors: | Ranabir Majumder Pratap Parida Samrat Paul |
| |
Institution: | 1. School of Bioscience and Engineering, Jadavpur University, Kolkata, India;2. School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, India |
| |
Abstract: | Abstract Aloe vera leaf contains some bioactive compounds that have a strong binding affinity toward estrogen receptor as compared to standard drug tamoxifen. In this study, we have found that the IC50 of Aloe vera leaf extract against breast cancer cell line (MCF-7) is 23?µg/mL which is much lower than the IC50 (332?µg/mL) of Aloe vera leaf extract against non-cancerous cell line (NIH-3T3). We have also calculated the total concentration of phenolic acid (385.662?µg/mL), flavonoids (160.402?µg/mL) and alkaloids (276.754?µg/mL) in Aloe vera leaf extract. The free radical scavenging activity of Aloe vera leaf extract is 67% to 89% (at 50 to 300?µg/ml). Our virtual molecular docking study suggests that bioactive compounds like Aloe-emodin (?8.8?Kcal/mol), 7-hydroxy-2,5 dimethylchromone (?7.5?Kcal/mol), Beta-sitosterol (?7.3?Kcal/mol) etc. have a greater binding affinity toward estrogen alpha receptor as compared to standard drug Tamoxifen (?6.4?Kcal/mol). ![/></span></td>
</tr>
<tr>
<td align=](/na101/home/literatum/publisher/tandf/journals/content/gnpl20/2020/gnpl20.v034.i16/14786419.2018.1534848/20200727/images/medium/gnpl_a_1534848_ilg0001_c.jpg) | |
Keywords: | Aloe vera estrogen receptor MTT assay virtual molecular docking MCF-7 |
|
|